Press Releases

MIAMI, FL April 21, 2020 – ArisGlobal, the leading provider of software that automates core drug development functions for over 300 life sciences companies, today announced the release of LifeSphere® CTMS10, a modern, end-to-end solution that makes the entire clinical trial management process easier and more transparent for companies of all sizes.

Offering global oversight and visibility, LifeSphere CTMS10 enables life sciences organizations to plan, track and control all trial set-up, conduct and closeout activities using a simple, intuitive interface designed for all levels of experience. Unlike other CTMS applications, LifeSphere CTMS10 also includes payments and monitoring modules out-of-the-box, ensuring fast, accurate disbursements to research sites and maximizing CRA effectiveness in the field.

With an innovative approach to delivering rapid study startup, LifeSphere CTMS10 helps clinical teams be more efficient and conduct faster trials by automating core activities like study planning, site assessments, investigator selection, enrollment planning, document distribution, and site visit planning.

“Trials have grown in cost and complexity, and it is increasingly difficult for teams to manage stakeholders, maintain oversight, and meet tight timelines,” said Sondra Pepe, Senior Director of Clinical Product Management at ArisGlobal. “LifeSphere CTMS10 was designed to solve these challenges through simplicity and an all-in-one approach that includes everything an organization needs to run an efficient, streamlined trial out-of-the-box.”

Part of the unified LifeSphere Clinical cloud platform, which includes LifeSphere eTMF and LifeSphere EDC, LifeSphere CTMS10 seamlessly connects clinical operations with data management to give teams full visibility and control over trial execution.

Learn more: For more on LifeSphere Clinical Trial Management System, visit: https://www.arisglobal.com/products/lifesphere-clinical-trial-management-system/.

About ArisGlobal